Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05537701 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

Study acronym: TEN
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 2023 to Mar 31, 2027v5 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 400 to confirmed 316
    • Study completion date: Dec 2023 to Mar 31, 2027
    • Site details revised
  2. Primary completion date: Nov 2022 to Nov 2023
    • Study completion date: Dec 2022 to Dec 2023
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2022 to Oct 3, 2022
    v3
  4. Primary endpoint revisedv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective is to describe eosinophil infiltration in resected (early stage) NSCLC. Secondary objectives are: * to investigate the correlation of T-Eos and B-Eos in the aforementioned patient population; * to investigate the correlation between T-Eos and overall \& disease-free survival; * to investigate the localization of T-Eos (periphery vs. center of the tumor lesions).
Trial Details
NCT Number NCT05537701
Lead Sponsor Centre Hospitalier Universitaire de Liege
Conditions
(from sponsor)		 Non-small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung
Enrollment 316 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov